Upcoming Medical Conferences in New YorkSearch Criteria : United States of America New York
Feb 08, 2020 | New York, New York
16th Annual International Symposium on Melanoma and Other Cutaneous Malignancies is organized by Physicians' Education Resource, LLC (PER) and will be held on Feb 08, 2020 at InterContinental New York Times Square, New York, United States of America. Target Audience This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate. What you will learn: • The current use of checkpoint inhibitors and other immunotherapeutic strategies, including intralesional therapies, both as single-agent therapy and in combination with other regimens • Insights into emerging therapeutic targets, including agents targeting LAG3, STING, and other pathways • Best practices for use of BRAF/MEK inhibitors as single-agent therapy and in combination with other therapies • Management strategies in the setting of regional disease and metastatic disease • Strategies for the mitigation of potential adverse events with targeted treatments and checkpoint inhibitors Benefits of Attending: • Interact with top experts in the field of cutaneous malignancies • Gain actionable insights to improve the treatment of your patients • Recognize the role of targeted therapies, checkpoint inhibitors, and combination therapies across the cutaneous malignancies • Recognize current best practices for management of adverse events with targeted therapies and checkpoint inhibitors • Network with colleagues and peers Overview This is a single-day educational conference discussing emerging treatments in melanoma, basal cell carcinoma, squamous cell carcinoma, and Merkel cell carcinoma. This concise and engaging program will inform your practice with insights from world-renowned experts on evolving standards of care in melanoma and other cutaneous malignancies. Learning Objectives At the conclusion of this symposium, you should be better prepared to: • Recognize best practices form the latest clinical trials in cutaneous malignancies to manage the full range of cutaneous malignancies across stages of disease • Understand best practice for multidisciplinary identification and management of the adverse events associated with treatment across cutaneous malignancies • Outline best practices for use of biomarkers in personalizing care in patients with melanoma, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, and other cutaneous malignancies • Contextualize current evidence in terms of evolving standards of care to support the optimal sequencing of therapies across melanoma, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, and other cutaneous malignancies
Mar 01, 2020 | CME 7.50 | USD $1699 | New York, New York
Anti-Aging - Modules 1 & 2 is organized by Empire Medical Training (EMT), Inc and will be held on Mar 01, 2020 at The Westin New York at Times Square, New York City, New York, United States of America. Target Audience: This activity designed to meet the educational needs of physicians, physician assistants, nurses and other healthcare professionals interested in treatment of pain management. Accreditation: Physicians AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Nurses AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is awarded 7.5 Contact Hours. Description: This 9-hour, intensive course has been expanded to include both Modules 1 and 2. The Anti Aging program is a very detailed oriented, comprehensive program for Physicians and other Health Care Professionals who are interested in integrating this new specialty into their practice. The program is taught by our lead instructor and Physician Advisory Board Director, Ann Robins, MD, a Board Certified Specialist in Internal Medicine and Anti-Aging Medicine and a graduate from the prestigious Yale University School of Medicine. Dr. Robins is also residency trained from the Mayo Clinic in St Paul, MN. In addition to her advisory role with Empire Medial Training, Dr Robins maintains a very busy Internal Medicine Practice with a focus on Regenerative and Weight Management Medicine. Anti-aging medicine compliments conventional medicine, the specialty originated on using and applying advanced scientific methods for the early detection, prevention, treatment, and reversal of age-related dysfunction, chronic disorders, and other health related diseases. Anti-aging is a healthcare model based upon evidenced based interventional medical care that are consistent with those applied in other preventive health specialties. The anti-aging medical model will allow you to both extend lifespan as well as prolong the health span for patients allowing them a greater period of time that they may live productively and independently. Learning Objectives: • Competently administer personalized anti-aging services to their patient in order to optimize outcomes. • Describe the risks, pitfalls and potential health risks of patients undergoing anti-agng treatments. • Apply generally accepted protocols of integrative approaches to anti-aging services. • Evaluate laboratory and clinical testing, patient and family histories, and other associated findings to enhance patient outcomes while utilizing the best approach to treatment. • Monitor potential complications arising from anti-aging procedures and treat effectively to provide optimal patient outcomes. Additional details will be posted as soon as they are available.
Memorial Sloan Kettering 8th Annual Hematology and Medical Oncology Board Review: Contemporary Practice
Mar 06 - 09, 2020 | 9 32.25 | New York, New York
Internal Medicine | Pediatric Hematology and Bone Marrow Transplant | Hematology Blood and Marrow Transplant | Oncology
8th Annual Hematology and Medical Oncology Board Review: Contemporary Practice is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held on Mar 06-09, 2020 at Mortimer B. Zuckerman Research Center, New York City, New York, United States of America. Target Audience:The target audience for this course is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents. Overview:This four-day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology. Live Simulcast Available:We are pleased to offer a live simulcast for this course, available to all non-MSK employees. CME and ABIM MOC credit is offered for the live simulcast and active participation is required throughout the course. We do hope you will attend in person but understand that can sometimes be a challenge, so we are happy to offer the live simulcast as an option. Registration for the simulcast is required; please select the "Live Simulcast" option during course registration. A link to view the Symposium will be emailed to you the day before the course begins. Objectives:By attending this course, attendees will:• Learn state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers• Learn state-of-the-science in diagnosis, staging, and therapeutic management of hematologic cancers• Understand recent treatment advances in solid tumor and hematologic oncology and their impact on modern clinical practice Additional details available here: mskcc.org/HemOncBoardReview
Mar 07 - 08, 2020 | CE Hours 16.00 | USD $575 | New York, Connecticut
Comprehensive Treatment of the Foot & Ankle is organized by Great Lakes Seminars (GLS) and will be held from Mar 07 - 08, 2020 at New York, Connecticut, United States of America. Accreditation: This course has been submitted for 16 continuing education hours. Approval amounts may vary per state. Certificates of attendance with the number of course hours will be given to each participant at the completion of the course. Course Description: This course takes a significantly different approach to treatment of the foot and ankle. It focuses on how to restore normal foot mechanics and take stress off of the soft tissues in the foot through manual techniques, taping and orthotic therapy. It shows you common foot dysfunctions that lead to common foot diagnoses. The manual therapy techniques covered include joint mobilizations and myofascial release / soft tissue mobilizations. You will make a pair of temporary orthotics in the class, utilizing a structural and functional approach, which can be easily replicated on Monday morning. As with all of our manual therapy courses, this seminar will follow a progression of principles and reinforce them throughout the 16 hours. This course is at least 75% hands-on lab, and will give the clinician hands-on skills they use immediately upon their return to the clinical setting. Topics Covered: • Introduction to a comprehensive approach to manual treatment of the foot & ankle • Overview of anatomy of the foot & ankle complex and its effect on mobilizations, MFR, etc • Introduction and review of the concepts of functional joint mobilization, MFR, foot taping, balance re-education and orthotic therapy • Mobilization: distal tib-fib, talocrural, subtalar, cuboid, navicular, misc tarsals • MFR: foot, ankle and lower extremity release techniques, scar releases • Taping: for the arch, ankle, navicular sling, peroneus longus, hallux valgus, calcaneal, fat pad • Orthotic therapy with temporary orthotics • Balance re-education of the foot & ankle complex • Application to specific clinical situations Course Objectives: At the completion of this seminar, the participant will be able to: • Demonstrate the ability to select the correct mobilization technique, myofascial technique, and correct taping, balance re-education or orthotic technique based on a patient's clinical presentation. • Demonstrate the correct hand technique, the correct grading of joint mobilization, and describe the specific physiologic effects of joint mobilization. • Demonstrate the correct specific techniques for MFR of the foot and lower extremity to treat foot and ankle dysfunctions. • Demonstrate the correct specific techniques for taping of the foot and ankle. Additional details will be posted as soon as information is available.
Mar 08 - 11, 2020 | New York, New York
Council of Residency Directors in Emergency Medicine (CORD) Academic Assembly is organized by the Council of Residency Directors in Emergency Medicine (CORD). The session is held from Mar 08 - 11, 2020 at New York Hilton Midtown, New York City, New York, United States of America. Additional details will be posted as soon as they are available.
Mar 08 - 11, 2020 | USD $1099 | New York, New York
Pharma Forum is the largest, most influential event for the world’s leading life sciences meeting management professionals. The symposium is held at the Marriott Marquis in New York City on March 8-11. It bestows you with elevating the experience with 55 expert speakers, expanded interactive formats to complement learning styles, customized programming based on experience level and new content streams. The Pharma Forum 2020 agenda features, 3 Conference Chairs 3 Never Before Seen Program Features 5 Impactful Keynote Speakers 15 Networking Hours 30 Educational Sessions 55 Expert Speakers – 51% New This Year And Much More! Download the complete agenda today at pharmameetingplanners.com Description: Pharma Forum is the go-to event that holds the world’s prominent life science gathering management professionals across the world. Corporate and third party planners assemble with suppliers and DMC partners to strengthen relationships and involve in an unmatched learning experience. Close to 800 professionals will unite at the 16 Annual programs in NYC to encounter the dynamic keynotes, thought-provoking panel sessions, collaborative exchanges, and actionable face-to-face networking Who Should Attend: You will benefit from attending this event if you are from a pharmaceutical, biotech or medical device company with responsibilities or involvement in the following areas, • Meeting Planning • Meeting Operations • Meeting Services • Congresses and Conventions • Exhibits and Events • Trade Shows • Procurement, Purchasing, Sourcing • Marketing • Compliance • Conference Management • Global Conference Management • Travel Management • Medical Communications • Professional Meetings This conference also profits hoteliers and other suppliers serving the medical meeting’s industry, as well as consultants, technology vendors and companies providing products and services in meeting logistics, execution, and reporting.
Mar 21, 2020 | CME 6.75 | USD $250 | New York, New York
MSK 2020 Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held on Mar 21, 2020 at Rockefeller Research Laboratories - MSKCC, New York City, New York, United States of America. Target Audience: The target audience for this course is Psychiatrists, Psycho-oncologists, Oncologists, Palliative Care Physicians, Physician Assistants, Nurse Practitioners, Nurses, Psychologists, Social Workers and Counselors. Accreditation: AMA Credit Designation Statement: Memorial Sloan Kettering Cancer Center designates this live activity for a maximum activity of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Social Work Accreditation Statement: This presentation is approved for a maximum of 6.50 Continuing Education Contact Hours of Live In-Person/Live Online Training. Memorial Sloan-Kettering Cancer Center is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0228. ANCC CNE Statement: 6.75 NCPD contact hours will be awarded to participants who attend a live program, in its entirety, and complete a program evaluation. Partial credit not awarded. Overview: Clinicians have numerous tools at their disposal to help adult cancer patients dealing with symptoms of depression, anxiety, and other cancer sequelae. Psychiatric medications are most frequently prescribed to cancer patients by oncologists and general practitioners, however psychiatric syndromes are often underdiagnosed and undertreated. Few oncology practices have dedicated psychiatric consultants familiar with the nuances of Psycho-Oncology. Even when patients receive psychotropic medications appropriately, they may have problems that arise before their next oncology visit or before they see the person who prescribed their psychiatric medications. Psychologists, nurses and social workers play an essential role in identifying psychological and physical symptoms as well as both beneficial and problematic medication effects as they provide frontline psychosocial interventions and support for cancer patients. This course is designed for the non-prescribing psycho-oncology clinician as well as the psychiatrist who is new to the world of Psycho-pharmaco-oncology. Oncologists, palliative care clinicians, advanced practice nurses and oncology nurses will find this course useful as well. The course will focus on key target disorders and symptoms amenable to psychopharmacological intervention, including anxiety, depression, delirium, sleep disturbance, pain, fatigue, and weight and appetite loss. Participants will learn to identify psychological reactions to medical conditions or treatments; psychiatric presentations of medical conditions or treatments; medical presentations of psychiatric conditions and common medical complications of psychiatric conditions or treatments. Basic information will be presented about medications used to alleviate Quality of Life symptoms that arise in the cancer setting from diagnosis to survivorship or end of life care, and the interface of psychotherapy and medication management. We will review why certain medications are used and why some are avoided, looking at potential benefits, unwanted side effects, and drug-drug interactions, since you may be the first person to identify a serious adverse event. The course will also enhance your ability to provide psychoeducation to patients regarding psychiatric medications. Live Simulcast Available: We are pleased to offer a live simulcast for this course, available to all non-MSK employees. CME credit is offered for the live simulcast and active participation is required throughout the course. We do hope you will attend in person but understand that can sometimes be a challenge, so we are happy to offer the live simulcast as an option. Registration for the simulcast is required; please select the "Live Simulcast" option during course registration. A link to view the Symposium will be emailed to you the day before the course begins. Objectives: Participants will learn basic psycho-pharmaco-oncology and how to hone essential clinical and observation skills to improve the quality of life, mental health and safety of their patients by understanding the basics of the psychophysiology of cancer.
Apr 03, 2020 | New York, New York
The course will address healthcare professionals with up-to-date information on the pros and cons of cannabis in patient care. Each major discpline will be covered targeting neurology. psychiatry, palliative care, oncology, addiction dental, chronic pain, public health and education in the use of cannabis. We will evaluate the use of cannabis therapeutics in the clinical setting and examine the role of these and other therapies by addressing proper protocol with major advances in both clinical and scientific areas. It is vital that our physicians and physician-scientists be regularly apprised on these latest advancements. The best teachers and clinicians from the Columbia University Irving Medical Center will present the material in lecture format. Twitter: https://go.evvnt.com/576749-3?pid=4828 Prices:General Admission - Doctore/Dentale CE: USD 199.0Livestreaming: USD 250.0General Admission - RN, PA, NP, Pharm, SW: USD 129.0 Speakers: Keynote speaker is Raphael Mechoulam PhD Hebrew University of Jerusalem, the Award Winning ‘Father of Cannabis Research’ Time: 8:00 am - 5:30 pm
Apr 03 - 04, 2020 | Contact Hours 10.50 | USD $540 | New York, New York
Onsite - 2020 Annual Hospital for Special Surgery (HSS) Sports Medicine Symposium is organized by Hospital for Special Surgery (HSS) and will be held from Apr 03 - 04, 2020 at Hospital For Special Surgery (HSS), New York, United States of America. This course has been approved for a maximum of 10.5 contact hours. Target Audience: This activity is targeted to physical therapists, physical therapist assistants, athletic trainers, strength and conditioning professionals, physician assistants, orthopaedists, sports medicine physicians, physiatrists, and primary care physicians. Residents, fellows, and students of medicine, physical therapy, and athletic training may also benefit from this activity. Description: The 2020 Annual HSS Sports Medicine Symposium will provide clinicians with guidance on how to care for surgical and nonsurgical patients among the sports medicine population. Topics to be discussed include the athlete’s hip, imaging, tears/repairs/rehab, advances in managing articular cartilage injuries, and much more. The best available evidence and state of the art information from the rehabilitation staff, surgeons, and physicians of Hospital for Special Surgery, along with guest lecturers, will provide participants with clinically relevant information through didactic lectures, panel discussions, case presentations, workshops, and demonstration. Learning Objectives: HSS continuing medical education activities are intended to improve the quality of patient care and safety. At the completion of the course, the participant should be able to: • Recognize each person’s role in the team approach (including ATC, MD, PA, PT and Performance Specialist) to providing outstanding patient care and appropriately referring patients to colleagues for treatment of injuries in the athletic population. • Incorporate at least one current evidence-based treatment guideline for treating articular cartilage injuries. • Identify at least two pertinent return-to-play principles following hip arthroscopy surgery. • Incorporate at least two evidence-based treatment strategies into their postsurgical treatment plan for rehabilitation of athletes with quadriceps/pecoralis major/Achilles tears. • Identify at least two training considerations for managing the adolescent athlete. • Describe current guidelines for return-to-play following a concussion. • List one technique to assess readiness to return to sport following an ulnar collateral ligament reconstruction. • Identify common injury patterns in the younger runner vs older runner.
Aortic Symposium is organized by American Association for Thoracic Surgery (AATS) and will be held from Apr 23 - 24, 2020 at New York Marriott Marquis, New York City, New York, United States of America. Program Overview: This two-day symposium focuses on the pathophysiology, diagnosis and treatment of aortic aneurysms and dissections. It is designed for cardiovascular and thoracic surgeons, residents, perfusionists, ICU and OR nurses and those involved with the care of individuals with aortic disease. The faculty consists of world leaders in this field who have been invited to share their experience regarding difficult problems in aortic disease. Additional details will be posted as soon as they are available.